Filtros de búsqueda

Lista de obras de

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas

artículo científico publicado en 2018

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

artículo científico publicado en 2019

Advanced stage melanoma therapies: Detailing the present and exploring the future

artículo científico publicado en 2018

Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?

artículo científico publicado en 2018

Central Nervous System Pseudoprogression With Nivolumab in a Patient With Squamous Cell Lung Cancer Followed by Prolonged Response

scientific article published on 01 September 2018

Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma

artículo científico publicado en 2019

Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010.

artículo científico publicado en 2013

Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events

scientific article published on 25 July 2019

Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review

scientific article published on 05 December 2019

Eribulin -- a review of preclinical and clinical studies.

artículo científico publicado en 2011

Eribulin in Cancer Treatment

artículo científico publicado en 2015

Eribulin in non-small cell lung cancer: challenges and potential strategies.

artículo científico publicado en 2017

Eribulin mesilate, a halichondrin B analogue, in the treatment of breast cancer

artículo científico publicado el 1 de septiembre de 2010

Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma

scientific article published on 01 December 2019

Experience with vena cava filters at a large community hospital and level-I trauma center: indications, complications, and compliance barriers

artículo científico publicado en 2013

Gastrointestinal stromal tumors-are we stuck and the way forward

artículo científico publicado en 2017

Harnessing DNA Replication Stress for Novel Cancer Therapy

scientific article published on 25 August 2020

Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and Challenges

scientific article published on 27 June 2019

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma

artículo científico publicado en 2020

Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies

artículo científico publicado en 2020

Quest for Ideal Composite Biomarkers for Response to Immunotherapies

artículo científico publicado en 2020

Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion

artículo científico publicado en 2018

Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement

artículo científico publicado en 2019

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study.

artículo científico publicado en 2017

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma

scientific article published on 29 March 2019

Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

artículo científico publicado en 2013

Toxicities with targeted therapies after immunotherapy in metastatic melanoma

scientific article published on 01 December 2018

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda